The U.S. Food and Drug Administration announced that two monoclonal antibody treatments for COVID-19 are currently not authorized for use due to their limited effectiveness against the Omicron variant. Omicron is still circulating widely in the U.S., including in Georgia. Monoclonal antibodies are synthetic, laboratory-created proteins that mimic the immune system’s ability to fight off the […]
